Rethinking nanoparticulate polymer–drug conjugates for cancer theranostics-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Rethinking nanoparticulate polymer–drug conjugates for cancer theranostics

Published:2022-06-23 Issue:1 Volume:15 Page:
ISSN:1939-5116
Container-title:WIREs Nanomedicine and Nanobiotechnology
language:en
Short-container-title:WIREs Nanomed Nanobiotechnol

Author:

Wang Yaoqi¹²³,Xia Heming⁴,Chen Binlong⁴^ORCID,Wang Yiguang⁴^ORCID

Affiliation:

1. School of Pharmaceutical Sciences Capital Medical University Beijing China

2. Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China Beijing China

3. Beijing Area Major Laboratory of Peptide and Small Molecular Drugs Beijing China

4. State Key Laboratory of Natural and Biomimetic Drugs School of Pharmaceutical Sciences, Peking University Beijing China

Funder

Beijing Municipal Natural Science Foundation

National Key Research and Development Program of China

National Natural Science Foundation of China

Publisher

Wiley

Subject

Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/wnan.1828

Reference115 articles.

1. The accelerated blood clearance (ABC) phenomenon: Clinical challenge and approaches to manage

2. Anticancer Activity Driven by Drug Linker Modification in a Polyglutamic Acid‐Based Combination‐Drug Conjugate

3. Self-immolative linkers in polymeric delivery systems

4. Nanoparticle and targeted systems for cancer therapy

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Application of Nanoparticles Targeting Cancer-Associated Fibroblasts;International Journal of Nanomedicine;2024-04

2. Stimuli-Responsive Polymeric Nanomedicine for Enhanced Cancer Immunotherapy;Chemistry of Materials;2024-01-29

3. Nanomaterials as Theranostic Agents for Cancer Therapy;ACS Applied Nano Materials;2023-11-29

4. Nanomedicine Combats Drug Resistance in Lung Cancer;Advanced Materials;2023-11-27

5. Targeted drug conjugate systems for ovarian cancer chemotherapy;Biomedicine & Pharmacotherapy;2023-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3